These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15845547)

  • 1. A structural basis for CD8+ T cell-dependent recognition of non-homologous peptide ligands: implications for molecular mimicry in autoreactivity.
    Sandalova T; Michaëlsson J; Harris RA; Odeberg J; Schneider G; Kärre K; Achour A
    J Biol Chem; 2005 Jul; 280(29):27069-75. PubMed ID: 15845547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2Db but not H-2Kb.
    Puglielli MT; Zajac AJ; van der Most RG; Dzuris JL; Sette A; Altman JD; Ahmed R
    J Virol; 2001 Jun; 75(11):5099-107. PubMed ID: 11333891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.
    Velloso LM; Michaëlsson J; Ljunggren HG; Schneider G; Achour A
    J Immunol; 2004 May; 172(9):5504-11. PubMed ID: 15100292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2D Kinetic Analysis of TCR and CD8 Coreceptor for LCMV GP33 Epitopes.
    Kolawole EM; Andargachew R; Liu B; Jacobs JR; Evavold BD
    Front Immunol; 2018; 9():2348. PubMed ID: 30374353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes.
    Gairin JE; Mazarguil H; Hudrisier D; Oldstone MB
    J Virol; 1995 Apr; 69(4):2297-305. PubMed ID: 7533855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against lymphocytic choriomeningitis virus infection induced by a reduced peptide bond analogue of the H-2Db-restricted CD8(+) T cell epitope GP33.
    Stemmer C; Quesnel A; Prévost-Blondel A; Zimmermann C; Muller S; Briand JP; Pircher H
    J Biol Chem; 1999 Feb; 274(9):5550-6. PubMed ID: 10026170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected T-cell recognition of an altered peptide ligand is driven by reversed thermodynamics.
    Allerbring EB; Duru AD; Uchtenhagen H; Madhurantakam C; Tomek MB; Grimm S; Mazumdar PA; Friemann R; Uhlin M; Sandalova T; Nygren PÅ; Achour A
    Eur J Immunol; 2012 Nov; 42(11):2990-3000. PubMed ID: 22837158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of tyrosine to the inflammation-associated analog 3'-nitrotyrosine at either TCR- or MHC-contact positions can profoundly affect recognition of the MHC class I-restricted epitope of lymphocytic choriomeningitis virus glycoprotein 33 by CD8 T cells.
    Hardy LL; Wick DA; Webb JR
    J Immunol; 2008 May; 180(9):5956-62. PubMed ID: 18424715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an epitope-specific CD8+ T-cell response on murine coronavirus central nervous system disease: protection from virus replication and antigen spread and selection of epitope escape mutants.
    Chua MM; MacNamara KC; San Mateo L; Shen H; Weiss SR
    J Virol; 2004 Feb; 78(3):1150-9. PubMed ID: 14722270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral escape at the molecular level explained by quantitative T-cell receptor/peptide/MHC interactions and the crystal structure of a peptide/MHC complex.
    Tissot AC; Ciatto C; Mittl PR; Grütter MG; Plückthun A
    J Mol Biol; 2000 Sep; 302(4):873-85. PubMed ID: 10993729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin.
    Achour A; Michaëlsson J; Harris RA; Ljunggren HG; Kärre K; Schneider G; Sandalova T
    J Mol Biol; 2006 Feb; 356(2):382-96. PubMed ID: 16375919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation threshold.
    Valkenburg SA; Gras S; Guillonneau C; La Gruta NL; Thomas PG; Purcell AW; Rossjohn J; Doherty PC; Turner SJ; Kedzierska K
    PLoS Pathog; 2010 Aug; 6(8):e1001039. PubMed ID: 20711359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
    Hudrisier D; Oldstone MB; Gairin JE
    Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells.
    Gallimore A; Hombach J; Dumrese T; Rammensee HG; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Oct; 28(10):3301-11. PubMed ID: 9808199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of viral antigens to major histocompatibility complex class I H-2Db molecules is controlled by dominant negative elements at peptide non-anchor residues. Implications for peptide selection and presentation.
    Hudrisier D; Mazarguil H; Laval F; Oldstone MB; Gairin JE
    J Biol Chem; 1996 Jul; 271(30):17829-36. PubMed ID: 8663374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structural basis for LCMV immune evasion: subversion of H-2D(b) and H-2K(b) presentation of gp33 revealed by comparative crystal structure.Analyses.
    Achour A; Michaëlsson J; Harris RA; Odeberg J; Grufman P; Sandberg JK; Levitsky V; Kärre K; Sandalova T; Schneider G
    Immunity; 2002 Dec; 17(6):757-68. PubMed ID: 12479822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effector cell function and altered tetramer binding of tumor-infiltrating lymphocytes.
    Blohm U; Roth E; Brommer K; Dumrese T; Rosenthal FM; Pircher H
    J Immunol; 2002 Nov; 169(10):5522-30. PubMed ID: 12421928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections.
    Bahl K; Kim SK; Calcagno C; Ghersi D; Puzone R; Celada F; Selin LK; Welsh RM
    J Immunol; 2006 Apr; 176(7):4284-95. PubMed ID: 16547266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a cross-reactive self ligand in virus-mediated autoimmunity.
    Ohteki T; Hessel A; Bachmann MF; Zakarian A; Sebzda E; Tsao MS; McKall-Faienza K; Odermatt B; Ohashi PS
    Eur J Immunol; 1999 Sep; 29(9):2886-96. PubMed ID: 10508263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-21-dependent modulation of T cell antigen receptor reactivity towards low affinity peptide ligands in autoreactive CD8(+) T lymphocytes.
    Bobbala D; Orkhis S; Kandhi R; Ramanathan S; Ilangumaran S
    Cytokine; 2016 Sep; 85():83-91. PubMed ID: 27300756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.